logo

DAVITA INC(NYSE:DVA)
DaVita Inc. is one of the largest providers of high-quality dialysis and related services for patients suffering from chronic kidney failure, also known as end stage renal disease. The company provides dialysis and ancillary services through a network of outpatient dialysis facilities.
# Employees: 32500
Address: 601 Hawaii Street,El Segundo,CA,USA
Phone: 310-536-2400
Fax: 310-792-8928
Website: www.davita.com
Email: ir@davita.com
Sector: Medical
Industry: MED-OUTP/HM CRE
Executive Officers
Kent J. Thiry (Chmn.; C.E.O.)
Charles G. Berg (Dir.)
James K. Hilger (V.P.; C.F.O.; Contro.; Princ. Acctg. Off.)
Willard W. Brittain (Dir.)
Peter T. Grauer (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/9/2010
Mean EPS (Next Qtr): $1.05
Mean EPS (Year): $4.05
Mean Estimate(Long Term): $12.95
P/E Ratio(Based on EPS estimate): 14.550
Number of Estimates: 13
Shares Performance
Period DVA Compare to S&P
YTD 18.92 % -1.58 %
4 Weeks 8.44 % 7.27 %
12 Weeks 13.98 % 7.46 %
Shares Information
Analyst Coverage: Y
Avg Volume: 963537
Shares Outstanding: 104M
Market Cap: $6.13B
52 Week High: $58.95
52 Week Low: $42.34
P/E Ratio: 14.960
PEG Ratio: 1.120
Split: On 6/16/2004 DVA split by factor of 1.500
Earnings Performance
EPS Growth in Last Quarter: 3.92 %
EPS Growth in Last Year: 19.10 %
Sales Growth in Last Quarter: 3.61 %
Sales Growth in Last Quarter: 8.76 %
Financials
Qtr Book Value: $2.87
Cash Flow/Share: $10.45
Change in Payout Ratio: 0.000
Price/Sales: 1.020
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia